Morgan Stanley’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-889,505
Closed -$16M 6976
2020
Q2
$16M Sell
889,505
-347,848
-28% -$6.26M ﹤0.01% 1577
2020
Q1
$8.82M Buy
1,237,353
+675,234
+120% +$4.81M ﹤0.01% 1900
2019
Q4
$13.4M Buy
562,119
+365,057
+185% +$8.72M ﹤0.01% 2080
2019
Q3
$5.29M Sell
197,062
-273,246
-58% -$7.33M ﹤0.01% 2825
2019
Q2
$12.8M Buy
470,308
+291,180
+163% +$7.9M ﹤0.01% 1903
2019
Q1
$6.22M Sell
179,128
-2,183,281
-92% -$75.8M ﹤0.01% 2503
2018
Q4
$46.1M Buy
2,362,409
+2,046,772
+648% +$40M 0.01% 852
2018
Q3
$8.41M Sell
315,637
-182,630
-37% -$4.86M ﹤0.01% 2591
2018
Q2
$18.8M Buy
498,267
+154,292
+45% +$5.83M 0.01% 1699
2018
Q1
$11.2M Buy
343,975
+34,574
+11% +$1.13M ﹤0.01% 2238
2017
Q4
$15.1M Sell
309,401
-24,461
-7% -$1.19M ﹤0.01% 1959
2017
Q3
$18M Buy
333,862
+7,037
+2% +$380K 0.01% 1683
2017
Q2
$18.4M Sell
326,825
-228,922
-41% -$12.9M 0.01% 1607
2017
Q1
$21.8M Sell
555,747
-565,215
-50% -$22.2M 0.01% 1478
2016
Q4
$25.2M Buy
1,120,962
+866,047
+340% +$19.4M 0.01% 1339
2016
Q3
$5.79M Sell
254,915
-133,524
-34% -$3.03M ﹤0.01% 2526
2016
Q2
$9.17M Buy
388,439
+96,505
+33% +$2.28M ﹤0.01% 2055
2016
Q1
$5.96M Buy
291,934
+56,986
+24% +$1.16M ﹤0.01% 2362
2015
Q4
$12.1M Buy
234,948
+15,853
+7% +$816K ﹤0.01% 1802
2015
Q3
$9.34M Buy
219,095
+34,064
+18% +$1.45M ﹤0.01% 2019
2015
Q2
$8.43M Sell
185,031
-50,539
-21% -$2.3M ﹤0.01% 2280
2015
Q1
$8.94M Buy
235,570
+122,884
+109% +$4.66M ﹤0.01% 2170
2014
Q4
$3.19M Buy
112,686
+57,857
+106% +$1.64M ﹤0.01% 3155
2014
Q3
$1.39M Buy
54,829
+2,422
+5% +$61.2K ﹤0.01% 3749
2014
Q2
$1.53M Sell
52,407
-87,107
-62% -$2.54M ﹤0.01% 3706
2014
Q1
$3.61M Buy
139,514
+60,777
+77% +$1.57M ﹤0.01% 2891
2013
Q4
$2.03M Buy
78,737
+12,982
+20% +$334K ﹤0.01% 3369
2013
Q3
$1.76M Sell
65,755
-16,792
-20% -$449K ﹤0.01% 3332
2013
Q2
$2.03M Buy
+82,547
New +$2.03M ﹤0.01% 3142